Sunday , April 23 2017
Home / Fashion / Health & Fitness / AbbVie Challenges Justness Of Upcoming Testosterone Trials

AbbVie Challenges Justness Of Upcoming Testosterone Trials

The lawsuit alleges that AbbVie and other testosterone producers endangered healthy men by marketing the hormone to treat sexual dysfunction, age-related fatigue and other symptoms that go beyond what the product is approved by the FDA to treat (hypogonadism, a serious hormonal decline caused by disease or injury). AbbVie ABBV -0.07%, maker of the popular AndroGel. Six so-called bellwether trials will begin in October 2016.

 

Click Here For the Entire Article

About admin

Check Also

1

Whey Protein Role In Aging

“Developing further from its traditional role as an excellent source of protein for muscle building ...

Leave a Reply

Your email address will not be published. Required fields are marked *

Vitamins